295 Accumulation of 53BP1 in circulating tumor cells during treatment with eribulin identifies chemotherapy-responsive metastatic breast cancer patients
Source : https://ijgc.bmj.com/content/30/Suppl_4/A98.1.full
Introduction/Background Evidence suggests that the DNA end-binding protein p53-binding protein 1 (53BP1) expression in breast cancer is associated with poor prognosis, especially in triple-negative breast cancer (TNBC). Circulating tumor cells...
Abstract PO-020: Impact of CDK 4/6i withdrawal or dose adjustment on COVID-19 incidence in HR+/HER2- mBC patients during the pandemic
Source : https://clincancerres.aacrjournals.org/content/26/18_Supplement/PO-020.abstract
AACR Virtual Meeting: COVID-19 and Cancer; July 20-22, 2020 Background: On January 30th, 2020, the World Health Organization (WHO) declared public health emergencies of international concern (PHEIC) because of the...
Statins and endocrine resistance in breast cancer
Source : https://cdrjournal.com/article/view/3885
Views: 63 | Downloads: 7 | Citations: 0 Views:63 | Downloads:7 | Citations:Comments:0 | 0 | :1 Academic Editor: Godefridus J. Peters | Copy Editor: Xi-Jun Chen | Production Editor:...
Baseline characteristics of patients from Asia enrolled in monarchE, evaluating abemaciclib in high risk early breast cancer | OncologyPRO
Abstract LBA1 Approximately 90% of patients with breast cancer are diagnosed at an early stage. While the risk of recurrence for many patients with HR+, HER2- early breast cancer (EBC)...
